Literature DB >> 4122780

Sustained-release levodopa.

A C Woods, G A Glaubiger, T N Chase.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4122780     DOI： 10.1016/s0140-6736(73)91718-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Controlled release levodopa treatment of motor fluctuations in Parkinson's disease.

Authors:  J L Juncos; G Fabbrini; M M Mouradian; C Serrati; A M Kask; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

Review 2.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

3.  Controlled-release levodopa/benserazide (Madopar HBS): clinical observations and levodopa and dopamine plasma concentrations in fluctuating parkinsonian patients.

Authors:  A O Ceballos-Baumann; R von Kummer; W Eckert; H Weicker
Journal:  J Neurol       Date:  1990-02       Impact factor: 4.849

4.  "On-off" phenomenon in Parkinson's disease: correlation to the concentration of dopa in plasma.

Authors:  T Eriksson; T Magnusson; A Carlsson; A Linde; A K Granérus
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.